Oncotarget
The cover for issue 26 of Oncotarget features Figure 6, "Mislocalization of IQGAP1-BRCA1 in human TNBC tumors phenocopies the dominant mutants and the TNBC cells," by Osman, et al.
miR-708-5p targets oncogenic prostaglandin E2 production to suppress a pro-tumorigenic phenotype in lung cancer cells |
https://doi.org/10.18632/oncotarget.27614 Nicholas J. Monteleone, and Carol S. Lutz |
2464-2483 |
Abstract | PDF | Full Text | Supplementary Information | How to cite | Press Release | Podcast | Order a Reprint |
The role of miRNA-133b and its target gene SIRT1 in FAP-derived desmoid tumor |
https://doi.org/10.18632/oncotarget.27622 Maria Teresa Rotelli, Maria Grazia Refolo, Catia Lippolis, Aldo Cavallini, Arcangelo Picciariello, Domenico Piscitelli, and Donato Francesco Altomare |
2484-2492 |
Abstract | PDF | Full Text | How to cite | Press Release | Podcast | Order a Reprint |
IQGAP1 control of centrosome function defines distinct variants of triple negative breast cancer |
https://doi.org/10.18632/oncotarget.27623 Mahasin A. Osman, William James Antonisamy, and Evgeny Yakirevich |
2493-2511 |
Abstract | PDF | Full Text | How to cite | Press Release | Podcast | Order a Reprint |
Inhibition of the RUNX1-CBFβ transcription factor complex compromises mammary epithelial cell identity: a phenotype potentially stabilized by mitotic gene bookmarking |
https://doi.org/10.18632/oncotarget.27637 Joshua T. Rose, Eliana Moskovitz, Joseph R. Boyd, Jonathan A. Gordon, Nicole A. Bouffard, Andrew J. Fritz, Anuradha Illendula, John H. Bushweller, Jane B. Lian, Janet L. Stein, Sayyed K. Zaidi, and Gary S. Stein |
2512-2530 |
Abstract | PDF | Full Text | Supplementary Information | How to cite | Order a Reprint |
Potential use of lenvatinib for patients with unresectable hepatocellular carcinoma including after treatment with sorafenib: Real-world evidence and in vitro assessment via protein phosphorylation array |
https://doi.org/10.18632/oncotarget.27640 Tetsu Tomonari, Yasushi Sato, Hironori Tanaka, Takahiro Tanaka, Yasuteru Fujino, Yasuhiro Mitsui, Akihiro Hirao, Tatsuya Taniguchi, Koichi Okamoto, Masahiro Sogabe, Hiroshi Miyamoto, Naoki Muguruma, Harumi Kagiwada, Masashi Kitazawa, Kazuhiko Fukui, Katsuhisa Horimoto, and Tetsuji Takayama |
2531-2542 |
Abstract | PDF | Full Text | Supplementary Information | How to cite | Order a Reprint |
IGF-1 and hyperglycaemia-induced FOXA1 and IGFBP-2 affect epithelial to mesenchymal transition in prostate epithelial cells |
https://doi.org/10.18632/oncotarget.27650 Rehanna Mansor, Jeff Holly, Rachel Barker, Kalina Biernacka, Hanna Zielinska, Anthony Koupparis, Edward Rowe, Jon Oxley, Alex Sewell, Richard M. Martin, Athene Lane, Lucy Hackshaw-McGeagh, and Claire Perks |
2543-2559 |
Abstract | PDF | Full Text | Supplementary Information | How to cite | Order a Reprint |
Influence of major BCR-ABL1 transcript subtype on outcome in patients with chronic myeloid leukemia in chronic phase treated frontline with nilotinib |
https://doi.org/10.18632/oncotarget.27652 Alexis Genthon, Franck Emmanuel Nicolini, Françoise Huguet, Carole Colin-Gil, Marc Berger, Sandrine Saugues, Alexandre Janel, Sandrine Hayette, Pascale Cohny-Makhoul, Nadine Cadoux, Jean-Michel Cayuela, Lydia Campos, Denis Guyotat, and Pascale Flandrin-Gresta |
2560-2570 |
Abstract | PDF | Full Text | Supplementary Information | How to cite | Order a Reprint |
Renal cell tumors convert natural killer cells to a proangiogenic phenotype |
https://doi.org/10.18632/oncotarget.27654 Yue Guan, Christopher B. Chambers, Taylor Tabatabai, Ha Hatley, Kristin R. Delfino, Kathy Robinson, Shaheen R. Alanee, Sophia Ran, Donald S. Torry, and Andrew Wilber |
2571-2585 |
Abstract | PDF | Full Text | Supplementary Information | How to cite | Order a Reprint |
Correction: Nucleolin represses transcription of the androgen receptor gene through a G-quadruplex |
https://doi.org/10.18632/oncotarget.27661 Cindy K. Miranti, Sara Moore, Yongeun Kim, Venkateshwar Reddy Chappeta, Kui Wu, Biswanath De, Vijay Gokhale, Laurence H. Hurley, and Elsa M. Reyes-Reyes |
2586-2586 |
Correction | PDF | How to cite |
Copyright © 2021 Impact Journals, LLC
Impact Journals is a registered trademark of Impact Journals, LLC